Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses renal cysts. These are very common, especially in individuals over the age of 50, and are usually asymptomatic.…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, highlights that CKD is more common than realized, affecting about 37 million adults in the US, but 90% may not be…
Majd Isreb, MD, FACP, FASN, IFMCP, from the Integrative Kidney Institute, discusses the link between inflammation and chronic kidney disease (CKD). He explains that CKD patients have higher…
This webinar snippet features Neera Dahl, MD, PhD, professor of medicine, medical director of nephrology, and director of the Nephrology Clinical Trials Program at Yale School of Medicine,…
A Kishore Kumar, MD, DM, a consultant nephrologist and renal transplant physician at PACE Hospitals, discusses high blood potassium levels in patients with kidney disease. For patients with…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses the complications of kidney disease. Kidney disease can affect the body’s ability to filter blood, balance chemicals, and can lead…
